- Home
- OSUR vs SPXX Comparison
OSUR vs SPXX Comparison
Compare OSUR & SPXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- SPXX
- Stock Information
- Founded
- OSUR 2000
- SPXX 2004
- Country
- OSUR United States
- SPXX United States
- Employees
- OSUR N/A
- SPXX N/A
- Industry
- OSUR Medical/Dental Instruments
- SPXX Trusts Except Educational Religious and Charitable
- Sector
- OSUR Health Care
- SPXX Finance
- Exchange
- OSUR Nasdaq
- SPXX Nasdaq
- Market Cap
- OSUR 334.1M
- SPXX 294.7M
- IPO Year
- OSUR 1986
- SPXX N/A
- Fundamental
- Price
- OSUR $4.13
- SPXX $16.89
- Analyst Decision
- OSUR Buy
- SPXX
- Analyst Count
- OSUR 3
- SPXX 0
- Target Price
- OSUR $6.67
- SPXX N/A
- AVG Volume (30 Days)
- OSUR 459.6K
- SPXX 51.3K
- Earning Date
- OSUR 11-05-2024
- SPXX 01-01-0001
- Dividend Yield
- OSUR N/A
- SPXX 7.55%
- EPS Growth
- OSUR N/A
- SPXX N/A
- EPS
- OSUR 0.36
- SPXX N/A
- Revenue
- OSUR $273,535,000.00
- SPXX N/A
- Revenue This Year
- OSUR N/A
- SPXX N/A
- Revenue Next Year
- OSUR N/A
- SPXX N/A
- P/E Ratio
- OSUR $11.35
- SPXX N/A
- Revenue Growth
- OSUR N/A
- SPXX N/A
- 52 Week Low
- OSUR $3.92
- SPXX $13.57
- 52 Week High
- OSUR $8.45
- SPXX $16.05
- Technical
- Relative Strength Index (RSI)
- OSUR 45.49
- SPXX 61.69
- Support Level
- OSUR $4.00
- SPXX $16.77
- Resistance Level
- OSUR $4.16
- SPXX $16.87
- Average True Range (ATR)
- OSUR 0.08
- SPXX 0.11
- MACD
- OSUR 0.01
- SPXX 0.01
- Stochastic Oscillator
- OSUR 57.89
- SPXX 93.73
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.